HMCIB SPAC 3 (226340) - Total Liabilities

Latest as of September 2024: ₩29.73 Billion KRW ≈ $20.15 Million USD

Based on the latest financial reports, HMCIB SPAC 3 (226340) has total liabilities worth ₩29.73 Billion KRW (≈ $20.15 Million USD) as of September 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. For the complete balance sheet picture, see 226340 current and non-current assets.

HMCIB SPAC 3 - Total Liabilities Trend (2015–2023)

This chart illustrates how HMCIB SPAC 3's total liabilities have evolved over time, based on quarterly financial data. Explore 226340 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

HMCIB SPAC 3 Competitors by Total Liabilities

The table below lists competitors of HMCIB SPAC 3 ranked by their total liabilities.

Company Country Total Liabilities
Yapi Kredi Koray Gayrimenkul Yatirim Ortakligi AS
IS:KGYO
Turkey TL7.58 Billion
SR Accord
TA:SRAC
Israel ILA1.42 Billion
Legal & General Group PLC
LSE:LGEN
UK GBX610.73 Billion
Conduent Inc
NASDAQ:CNDT
USA $1.57 Billion
Nordic Aqua Partners As
OL:NOAP
Norway Nkr92.92 Million
Pioneer Municipal High Income Advantage Trust
NYSE:MAV
USA $51.06 Million
SEEING MACHINES LTD
F:M2Z
Germany €88.34 Million
Bursa Cimento Fabrikasi AS
IS:BUCIM
Turkey TL10.32 Billion

Liability Composition Analysis (2015–2023)

This chart breaks down HMCIB SPAC 3's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. Check financial resilience of HMCIB SPAC 3 to evaluate the company's liquid asset resilience ratio.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.71 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.54 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.33 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how HMCIB SPAC 3's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for HMCIB SPAC 3 (2015–2023)

The table below shows the annual total liabilities of HMCIB SPAC 3 from 2015 to 2023.

Year Total Liabilities Change
2023-12-31 ₩47.65 Billion
≈ $32.29 Million
-19.20%
2022-12-31 ₩58.97 Billion
≈ $39.96 Million
-3.55%
2021-12-31 ₩61.14 Billion
≈ $41.43 Million
+178.69%
2020-12-31 ₩21.94 Billion
≈ $14.87 Million
+208.43%
2019-12-31 ₩7.11 Billion
≈ $4.82 Million
-25.38%
2018-12-31 ₩9.53 Billion
≈ $6.46 Million
+891.73%
2017-12-31 ₩961.20 Million
≈ $651.39K
+3.41%
2016-12-31 ₩929.50 Million
≈ $629.91K
+3.73%
2015-12-31 ₩896.04 Million
≈ $607.24K
--

About HMCIB SPAC 3

KQ:226340 Korea Household & Personal Products
Market Cap
$193.33 Million
₩285.28 Billion KRW
Market Cap Rank
#16805 Global
#636 in Korea
Share Price
₩6800.00
Change (1 day)
+3.03%
52-Week Range
₩1224.00 - ₩8060.00
All Time High
₩8060.00
About

Bonne Co., Ltd. develops and supplies cosmetics in South Korea. The company offers skin care products, including whitening, wrinkle and pimple treatment, stem-cell peptide, and nano peptide products; and sun care products comprising fluids, creams, emulsions, etc. It also provides hair and body care products; makeup products, such as foundation, powder, compact, loose powder, BB cream, eye liner,… Read more